Calloway's Nursery Inc. CLWY
—
5.51
0.00
0.00%
as of 24 Sep
- Market cap
- —
- P/E
- 4.9×
Follow CLWY
| Older periods | Jun '22 | Sep '22 | Dec '22 | Mar '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | 12.09 |
P/S ratio |
— | — | — | 1.39 | |
P/FCF ratio |
— | — | — | 8.94 | |
P/Operating CF |
— | — | — | 14.10 | |
P/B ratio |
— | — | — | 3.90 | |
Price to Tangible BV |
— | — | — | 3.90 | |
EV/Sales |
— | — | — | 1.60 | |
EV/EBITDA |
— | — | — | 8.62 | |
EV/Operating CF |
— | — | — | 8.92 | |
EV/FCF |
— | — | — | 10.26 | |
Quick Ratio |
1.15 | 0.84 | — | 0.86 | |
Current Ratio |
1.85 | 1.67 | — | 1.52 | |
Net Debt/EBITDA |
0.00 | 0.00 | — | 4.87 | |
Debt/Assets |
36.53% | 32.79% | 0.00% | 35.34% | |
Debt/Equity |
1.04 | 0.98 | — | 1.12 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.94 | |
Operating CF/Net income |
0.00 | 0.00 | — | 4.67 | |
Capex/Depreciation |
(0.82) | (0.33) | — | (0.30) | |
Interest Coverage |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 40.67% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Graham Net Nets |
— | — | — | (0.29) | |
Graham Number |
— | — | — | 9.47 | |
Earnings Yield |
— | — | — | 8.27% | |
Free Cash Flow Yield |
— | — | — | 11.19% | |
Revenue per Share |
— | — | — | 2.73 | |
Operating CF per Share |
0.00 | 0.00 | — | 0.97 | |
Capex per Share |
0.00 | 0.00 | — | (0.03) | |
Free Cash Flow per Share |
0.00 | 0.00 | — | 0.94 | |
Cash per Share |
0.00 | 0.00 | — | 1.90 | |
Shareholders Equity per Share |
0.00 | 0.00 | — | 3.52 | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
0.00 | 0.00 | — | 3.52 | |
Free Cash Flow |
7.55 | (4.32) | — | 7.19 | |
Working Capital |
11.52 | 9.00 | — | 9.47 | |
Capital Expenditures |
(0.60) | (0.26) | — | (0.23) | |
Net Current Asset Value |
(29.77) | (31.63) | — | (30.17) | |
EV/EBIT |
— | — | — | 10.12 | |
Capex to Sales |
0.00 | 0.00 | — | 0.01 | |
Net Profit Margin |
— | — | — | 7.64% | |
Price to Operating Income |
— | — | — | 8.81 | |
| Other line items | |||||
Average Receivables |
0.94 | 0.69 | — | 0.93 | |
Average Payables |
14.38 | 12.12 | — | 13.17 | |
Average Inventory |
7.78 | 8.03 | — | 9.11 | |
Average Assets |
84.86 | 78.71 | 0.00 | 80.09 | |
Average Common Equity |
29.04 | 29.94 | — | 28.05 |
Columns are period end dates